Dabigatran versus Warfarin in Patients with Atrial Fibrillation-Reference-Cited by-同舟云学术

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

Published:2009-09-17 Issue:12 Volume:361 Page:1139-1151
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Connolly Stuart J.,Ezekowitz Michael D.,Yusuf Salim,Eikelboom John,Oldgren Jonas,Parekh Amit,Pogue Janice,Reilly Paul A.,Themeles Ellison,Varrone Jeanne,Wang Susan,Alings Marco,Xavier Denis,Zhu Jun,Diaz Rafael,Lewis Basil S.,Darius Harald,Diener Hans-Christoph,Joyner Campbell D.,Wallentin Lars

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa0905561

Cited by 9457 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atrial fibrillation management in older hospitalized patients: Evidence of a poor oral anticoagulants prescriptive attitude from the Italian REPOSI registry;Archives of Gerontology and Geriatrics;2025-01

2. The use of reduced DOAC doses in atrial fibrillation patients does not always lead to good anticoagulation levels and avoid adverse events;International Journal of Cardiology;2024-12

3. Synthetic routes and clinical application of new drugs approved by EMA during 2023;European Journal of Medicinal Chemistry;2024-11

4. Not all cost conversations are the same: An exploration of potential value in cost conversations during Atrial fibrillation treatment decision making;Patient Education and Counseling;2024-11

5. Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design;American Heart Journal;2024-11